The U.S. FDA said that BD (NYSE:BDX) has expanded its Class I voluntary recall to inform customers about the worst-case performance of the BD Alaris Pump Module model 8100 when used with certain ...
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued a voluntary recall related to certain Alaris™ and BD Alaris™ Pump Modules that may have been ...
Feb 6 (Reuters) - Cardinal Health Inc. said it reached an agreement with the U.S. Food and Drug Administration on a consent decree regarding its Alaris infusion pumps. The agreement, which is subject ...
A vulnerability found in software used to monitor some of BD’s infusion pumps could potentially give hackers access to personal data stored in the system. BD posted a cybersecurity bulletin about the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback